Home › Breaking News › US is requiring weight-loss drug makers to warn about...
Breaking News

US is requiring weight-loss drug makers to warn about possible loss of eye sight

US is requiring weight-loss drug makers to warn about possible loss of eye sight
Key Points

US is requiring weight-loss drug makers to warn about possible loss of eye sight Close to 30 million Americans are taking the drugs - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in The makers of blockbuster weight loss drugs such as Ozempic and Zepbound will be required to include warnings about a rare eye condition that can cause permanent vision loss. Taking GLP-1 drugs carries an increased risk of a condition known as...

US is requiring weight-loss drug makers to warn about possible loss of eye sight Close to 30 million Americans are taking the drugs - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in The makers of blockbuster weight loss drugs such as Ozempic and Zepbound will be required to include warnings about a rare eye condition that can cause permanent vision loss. Taking GLP-1 drugs carries an increased risk of a condition known as “non-arteritic anterior ischemic optic neuropathy,” or NAION, the U.S. Food and Drug Administration said Monday. Roughly 28 million Americans are taking the drugs, according to a July Gallup poll. This is a developing story. Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments
US (LOCATION) Americans (ORG) Independent (ORG) Ozempic (ORG) Zepbound (PERSON) NAION (ORG) the U.S. Food and Drug Administration (ORG) Gallup (ORG)
Originally published by The Independent World Read original →